CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Louisville, Kentucky, United States and 62 other locations
together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...
Phase 2
Louisville, Kentucky, United States and 32 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Louisville, Kentucky, United States and 226 other locations
look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...
Phase 3
Louisville, Kentucky, United States and 147 other locations
postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...
Phase 2
Louisville, Kentucky, United States and 50 other locations
The goal of this clinical trial is to assess the efficacy of DB-1303/BNT323 compared with investigator's choice chemotherapy in terms of progression-...
Phase 3
Louisville, Kentucky, United States and 126 other locations
A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer....
Phase 3
Louisville, Kentucky, United States and 446 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin...
Phase 2
Louisville, Kentucky, United States and 23 other locations
This research study is studying three combinations of drugs as treatments for breast cancer.The drugs involved in this study are:* ...
Phase 2
Louisville, Kentucky, United States and 21 other locations
ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...
Phase 3
Louisville, Kentucky, United States and 16 other locations
Clinical trials
Research sites
Resources
Legal